about
Allopurinol: insights from studies of dose-response relationships.Multiplicative interaction of functional inflammasome genetic variants in determining the risk of gout.Predicting allopurinol response in patients with goutUnderstanding the dose-response relationship of allopurinol: predicting the optimal dosage.Pharmacokinetics considerations for gout treatments.The impact of diuretic use and ABCG2 genotype on the predictive performance of a published allopurinol dosing tool.Individualising the dose of allopurinol in patients with gout.A population pharmacokinetic model to predict oxypurinol exposure in patients on haemodialysis.The population pharmacokinetics of allopurinol and oxypurinol in patients with gout
P2860
Q30240163-A01CD2D3-8B56-4947-9487-E38055B5393AQ36159273-647EA622-F920-45F3-9543-2E5837C390E0Q36802064-7FC7DB31-8C7F-4578-9C97-7468077C8688Q37353448-874834DA-BC22-4DCD-8108-6FA4EE9F6E70Q38210284-712A9ABC-3A0A-45A3-AF75-8DE705FF9312Q48228865-959CEA91-BCE3-41F7-B22B-B49EC609A899Q48266996-DEB77822-BF0F-4103-9FCA-8629103FD428Q51790528-0B49011E-40D6-456D-A252-0A032D21AA03Q57154764-1466DCFB-B2F2-4E57-811A-D6A852CF2261
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
The pharmacokinetics of oxypurinol in people with gout.
@ast
The pharmacokinetics of oxypurinol in people with gout.
@en
type
label
The pharmacokinetics of oxypurinol in people with gout.
@ast
The pharmacokinetics of oxypurinol in people with gout.
@en
prefLabel
The pharmacokinetics of oxypurinol in people with gout.
@ast
The pharmacokinetics of oxypurinol in people with gout.
@en
P2093
P2860
P50
P1476
The pharmacokinetics of oxypurinol in people with gout.
@en
P2093
Garry G Graham
Kenneth M Williams
Radojka M Savic
Sophie L Stocker
P2860
P304
P356
10.1111/J.1365-2125.2012.04207.X
P407
P577
2012-09-01T00:00:00Z